S3118E HBV Ultra – Hepatitis B Virus DNA Quantitative Fluorescence Diagnostic Kit
Hepatitis B Virus DNA Quantitative Fluorescence Diagnostic Kit (PCR-Fluorescence Probing) (HBV Ultra) is an in vitro nucleic acid amplification test for the quantification of Human HBV DNA in human serum. It is intended for use as an aid in diagnosing an HBV infection and observing drug efficacy.
Advanced magnetic beads technology
HBV DNA detection and viral load measurement are essential for treatment decisions and patient monitoring. Sansure’s HBV Ultra uses the advanced magnetic beads technology to extract HBV DNA from clinical Plasma. Our technology achieved high sensitivity and wide linear range detection to meet of clinical diagnosis and follow-up needs.
Highly conservative primer probe design
Sansure primers and probes target select the highly conservative S gene of HBV, which can cover A-H genotypes and avoid missed detection.
High-efficient quality control system
HBV Ultra uses UNG enzyme + dUTP system to remove carry-over contamination to avoid a false positive result.
HBV Ultra uses Internal Control
HBV Ultra uses Internal Control is the full name to whole-process the HBV extraction and amplification process to avoid false negative results.
|Extraction Platform||Advanced magnetic beads technology|
|Genotype||HBV genotype A-H|
|PCR Instrument||SLAN-96P, ABI7500, Roche cobas 480|
|Linear range||20—2.0E+09 IU/mL|